I am excited to share with you breaking news — Congress has included our requested $400 million increase in Alzheimer’s research funding at the National Institutes of Health (NIH) and is expected to approve this increase later this week. For the second consecutive year, Congress has heard and answered the call of the Alzheimer’s Association and taken historic action.
The bipartisan congressional effort was spearheaded by Sen. Roy Blunt (R-Mo.), Sen. Patty Murray (D-Wash.), Rep. Tom Cole (R-Okla.), and Rep. Nita Lowey (D-N.Y.) and comes on the heels of 1,300 advocates participating in the Alzheimer’s Association Advocacy Forum in Washington, D.C., and intense work by our sister organization, the Alzheimer’s Impact Movement (AIM).
With this action, Alzheimer’s research funding by the federal government will reach nearly $1.4 billion. This nearly threefold increase over five years in NIH funding for Alzheimer’s disease is a monumental accomplishment. Most importantly, it continues the ramp-up to providing Alzheimer’s researchers with the resources they so urgently need if we are to achieve the 2025 objective of preventing and effectively treating Alzheimer’s.
Today’s announcement would not have happened without your relentless work. Our work together as the Alzheimer’s Association and through AIM by all of our dedicated advocates and the generous supporters of both AIM and the Association have made this next step possible. Thank you for all of your contributions to making all of our advances possible.
We have much more yet to do, but please do pause and recognize what you’ve done, what we’ve accomplished together to bring us another step closer to a world without Alzheimer’s.